These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31381187)

  • 21. Prospective monitoring of cytomegalovirus, Epstein-Barr virus, BK virus, and JC virus infections on belatacept therapy after a kidney transplant.
    Bassil N; Rostaing L; Mengelle C; Kallab S; Esposito L; Guitard J; Cardeau-Desangles I; Weclawiak H; Izopet J; Kamar N
    Exp Clin Transplant; 2014 Jun; 12(3):212-9. PubMed ID: 24907721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study.
    Basso M; Andreis S; Scaggiante R; Franchin E; Zago D; Biasolo MA; Del Vecchio C; Mengoli C; Sarmati L; Andreoni M; Palù G; Parisi SG
    BMC Infect Dis; 2018 Dec; 18(1):683. PubMed ID: 30567494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Whole Blood and Plasma for Monitoring Cytomegalovirus and Epstein-Barr Virus.
    Fukuda Y; Torii Y; Iwata KI; Haruta K; Yamaguchi M; Suzuki T; Narita A; Muramatsu H; Ogura Y; Takahashi Y; Ito Y; Kawada JI
    New Microbiol; 2024 May; 47(1):52-59. PubMed ID: 38700884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid T cell repopulation after rabbit anti-thymocyte globulin (rATG) treatment is driven mainly by cytomegalovirus.
    Havenith SH; Remmerswaal EB; Bemelman FJ; Yong SL; van Donselaar-van der Pant KA; van Lier RA; Ten Berge IJ
    Clin Exp Immunol; 2012 Sep; 169(3):292-301. PubMed ID: 22861369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical Cytomegalovirus and Epstein-Barr Virus Shedding Is Associated with Increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.
    Chaillon A; Nakazawa M; Rawlings SA; Curtin G; Caballero G; Scott B; Anderson C; Gianella S
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32641485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
    Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H
    Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative monitoring of circulating Epstein-Barr virus DNA for predicting the development of posttransplantation lymphoproliferative disease.
    Ohga S; Kubo E; Nomura A; Takada H; Suga N; Ishii E; Suminoe A; Inamitsu T; Matsuzaki A; Kasuga N; Hara T
    Int J Hematol; 2001 Apr; 73(3):323-6. PubMed ID: 11345197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological and Liver Biomarkers Profile of Epstein-Barr Virus Infection and Its Coinfection with Cytomegalovirus in Patients with Hematological Diseases.
    Ferrari de Freitas L; de Melo Silva J; Nogueira Barbosa A; Miranda Santos E; Pinheiro-Silva R; Soares Pontes G
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients.
    Hornef MW; Bein G; Fricke L; Steinhoff J; Wagner HJ; Hinderer W; Sonneborn HH; Kirchner H
    Transplantation; 1995 Sep; 60(5):474-80. PubMed ID: 7676497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
    Kullberg-Lindh C; Olofsson S; Brune M; Lindh M
    Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
    Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
    Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent co-reactivation of Epstein-Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapy.
    Hatayama Y; Hashimoto Y; Motokura T
    J Int Med Res; 2020 Nov; 48(11):300060520972880. PubMed ID: 33249964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
    Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
    Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
    Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)].
    Brissot E; Alsuliman T; Gruson B; Hermet E; Tirefort Y; Yakoub-Agha I; Alain S
    Bull Cancer; 2017 Dec; 104(12S):S181-S187. PubMed ID: 29169653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia.
    Sakamoto T; Obara N; Maruyama Y; Kato T; Kurita N; Hattori K; Suehara Y; Nishikii H; Yokoyama Y; Sakata-Yanagimoto M; Usuki K; Chiba S
    Eur J Haematol; 2023 Nov; 111(5):768-776. PubMed ID: 37549934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation.
    Li SS; Zhang N; Jia M; Su M
    Front Cell Infect Microbiol; 2022; 12():818167. PubMed ID: 35402291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for and the Clinical Impact of Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Recipients of TCR-α/β- and CD19-Depleted Grafts.
    Laberko A; Bogoyavlenskaya A; Shelikhova L; Shekhovtsova Z; Balashov D; Voronin K; Kurnikova E; Boyakova E; Raykina E; Brilliantova V; Pirumova V; Novichkova G; Maschan A; Maschan M
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):483-490. PubMed ID: 28039080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen.
    Ru Y; Zhu J; Song T; Ding Y; Zhu Z; Fan Y; Xu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu C; Chen S; Ma X; Chen F; Chen J; Wu D
    Front Cell Infect Microbiol; 2022; 12():865170. PubMed ID: 35651756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.